Besremi Interactions
There are 449 drugs known to interact with Besremi (ropeginterferon alfa-2b), along with 10 disease interactions. Of the total drug interactions, 38 are major, and 411 are moderate.
- View all 449 medications that may interact with Besremi
- View Besremi disease interactions (10)
Most frequently checked interactions
View interaction reports for Besremi (ropeginterferon alfa-2b) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aimovig (erenumab)
- Allegra (fexofenadine)
- amitriptyline
- armodafinil
- aspirin
- atorvastatin
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- boswellia / cholecalciferol / glucosamine
- bupropion
- cannabis
- Carafate (sucralfate)
- celecoxib
- Centrum Silver (multivitamin with minerals)
- clonidine
- codeine / guaifenesin
- Crestor (rosuvastatin)
- diclofenac
- Flomax (tamsulosin)
- gabapentin
- hydrochlorothiazide
- Jakafi (ruxolitinib)
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- oxycodone
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
Besremi disease interactions
There are 10 disease interactions with Besremi (ropeginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- hepatic dysfunction
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- colitis
- diabetes mellitus
- myelosuppression
Report options
More about Besremi (ropeginterferon alfa-2b)
- Besremi consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic interferons
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Intron A
Intron A is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated lymphoid ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
PegIntron
PegIntron is used to treat chronic hepatitis C in adults. Learn about side effects, interactions ...
Sylatron
Sylatron (peginterferon alfa-2b) used to prevent malignant melanoma from coming back after it has ...
Ropeginterferon alfa-2b
Ropeginterferon alfa-2b systemic is used for polycythemia vera
Peginterferon alfa-2b
Peginterferon alfa-2b systemic is used for chronic myelogenous leukemia, hepatitis b, hepatitis c ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Ruxolitinib
Ruxolitinib (oral) is used to treat certain types of myelofibrosis (MF), polycythemia vera (PV) ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
